Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Real-Time PCR, Digital PCR And End-Point PCR Market From 2025 To 2029?
In recent times, the market size for real-time pcr, digital pcr and end-point pcr has experienced significant growth. Predictions for the market indicate an increase from $38.37 billion in 2024 to a robust $41.55 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.3%. This considerable growth during the historical period can be credited to factors such as the standardization of PCR protocols, its application in personalised medicine, role in drug discovery and development, and its widespread use in forensic and paternity testing.
The market size for real-time PCR, Digital PCR, and End-point PCR is set to experience significant expansion in the forthcoming years. Anticipated to expand to $60.73 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 10.0%, this growth can be tied to the broadening of molecular diagnostics, an escalation in infectious disease testing, growing demand for genetic testing, and deeper market penetration in areas of research and forensics, as well as the quick point-of-care PCR solutions. Key trends in the forecast period will include the emergence of digital assays, advancements in multiplex PCR, a shift towards digital PCR technology, automation in conjunction with high-throughput systems, and the miniaturization of PCR platforms.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13296&type=smp
Which Primay Drivers Are Accelerating Growth in the Real-Time PCR, Digital PCR And End-Point PCR Market?
The escalating prevalence of infectious diseases is predicted to fuel the advancement of the real-time PCR, digital PCR, and end-point PCR markets in future. These diseases are the result of the invasion and growth of harmful microbes such as bacteria, viruses, fungi, and parasites. Reagents like real-time PCR, digital PCR, and end-point PCR are employed in infectious diseases to measure specific pathogens or their genetic components, track disease progression, and swiftly detect infections like HIV, hepatitis, respiratory viruses, and tuberculosis. For instance, as reported by UNAIDS, a UN program based in Switzerland that targets the global HIV/AIDS epidemic, the worldwide population with HIV rose to 39 million in 2022, which is an increase of 3.17% from 37.7 million in 2020. Additionally, about 1.3 million new HIV infections were reported in 2022. Moreover, as per the Centers for Disease Control and Prevention, a national health organization from the USA, there were 8,300 tuberculosis (TB) cases reported in 2022 in the United States, that increased from 7,874 cases in 2021. Consequently, the augmentation in the prevalence of infectious diseases will fuel the growth of the cephalosporin market.
Which Primary Segments of the Real-Time PCR, Digital PCR And End-Point PCR Market Are Driving Growth and Industry Transformations?
The real-time pcr, digital pcr and end-point pcrmarket covered in this report is segmented –
1) By Product: Instruments; Consumables And Reagents; Software And Services
2) By Technology: Quantitative; End-Point Polymerase Chain Reaction (PCR); Digital
3) By Applications: Clinical; Research; Forensic; Other Applications
4) By End User: Hospital; Diagnostic Labs; Pharma; Biotech; Contract Research Organizations
Subsegments:
1) By Instruments: Real-Time PCR Systems; Digital PCR Systems; End-Point PCR Systems
2) By Consumables And Reagents: PCR Plates And Tubes; Primers And Probes; PCR Master Mix; DNA Polymerases And Nucleotides
3) By Software And Services: Analysis Software; Data Management Software; Calibration And Maintenance Services; Training And Support Services
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13296&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Real-Time PCR, Digital PCR And End-Point PCR Market?# Market?
North America was the largest region in the real-time PCR, digital PCR, and end-point PCR market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time PCR, digital PCR and end-point PCR market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Which Technological Trends Are Reshaping the Real-Time PCR, Digital PCR And End-Point PCR Industry Dynamics?
Key players in the real-time PCR, digital PCR, and end-point PCR markets are introducing revolutionary products built on sophisticated technologies such as digital polymerase chain reaction (dPCR) technology. This aims for a deeper understanding of a patient’s cancer, genetic illness, or infection. The dPCR technology is an advanced variation of traditional polymerase chain reaction methods that can accurately quantify and clonally amplify DNA, cDNA, or RNA strands. For example, in August 2022, the US-based pharmaceutical and medical instrument company, Roche Diagnostics, unveiled their next-generation digital PCR Digital LightCycler System. This system promises early detection and intervention for multiple chronic and genetic diseases. It has been created to mechanize workflow, eradicate the requirement for external calculations, software, and processors while ensuring high sensitivity and precision by integrating three nano well plate configurations, six progressive optical channels and 5x concentrated Master mixes of DNA and RNA. Roche’s diagnostic platform range has been enriched with the addition of the Digital LightCycler System; offering advanced technology, clinical applications, adaptability, and workflow automation.
View the full report here:
What Parameters Are Used to Define the Real-Time PCR, Digital PCR And End-Point PCR Market?
Real-time PCR (polymerase chain reaction), digital PCR, and endpoint PCR are different techniques in molecular biology and genetic analysis used to amplify and analyze DNA samples. Real-time polymerase chain reaction (PCR) is a laboratory technique to amplify and quantify DNA or RNA molecules. Digital PCR is the third generation of PCR that enables precise quantification by segregating a sample into numerous isolated compartments. Endpoint PCR, or conventional PCR, refers to a fundamental molecular biology technique used to amplify a specific DNA sequence from a sample. These PCR techniques are used in various clinical applications, such as bacteria detection, DNA fingerprinting, and genetic disorder diagnosis.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13296
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model